In a 32-year-old male with recent infective endocarditis, a 5.5 cm splenic infarction, mitral valve replacement, and severely reduced ejection fraction (15‑20 %), who has been started on guideline‑directed medical therapy and a heparin infusion, how should fluid management be approached?

Fluid Management in Endocarditis with Severe Heart Failure and Splenic Infarction

In this critically ill patient with severe cardiogenic shock (EF 15-20%) and a large splenic infarction on heparin, fluid administration must be extremely restrictive—aim for euvolemia or slight negative balance, guided by invasive hemodynamic monitoring and echocardiography, while avoiding volume overload that will worsen pulmonary edema and heart failure.

Clinical Context and Hemodynamic Priorities

This patient presents a high-risk scenario combining:

• Severe systolic dysfunction (EF 15-20%) with limited cardiac reserve
• Recent mitral valve replacement requiring careful preload optimization
• Large splenic infarction (5.5 cm) with bleeding risk on anticoagulation
• Active endocarditis with ongoing septic physiology

The severely reduced ejection fraction means this heart cannot accommodate volume loading without precipitating acute decompensation. The 2021 ACC/AHA valvular guidelines emphasize that in patients with significant mitral regurgitation and LV dysfunction, "judicious intravenous fluid administration" is critical "to avoid increases in LA pressure and pulmonary capillary pressure that may precipitate acute pulmonary edema" 1.

Specific Fluid Management Strategy

Initial Assessment and Monitoring

Establish invasive monitoring immediately:

• Place a pulmonary artery catheter or use serial echocardiography to assess:
  • Cardiac output/index (target CI ≥1.8 L/min/m²)
  • Pulmonary capillary wedge pressure (PCWP)
  • Right ventricular function
  • LV filling and stroke volume variation

The 2025 ESICM shock guidelines strongly support echocardiography as first-line for hemodynamic assessment in all shock states, with documented therapeutic impact in 38-68% of cases 2. The 2021 ACC/AHA guidelines specifically recommend "periprocedural hemodynamic monitoring with a right-heart catheter or intraoperative TEE" for continuous optimization of loading conditions in patients with severe valvular disease and heart failure 1.

Volume Status Targets

Maintain euvolemia, NOT volume expansion:

• Target PCWP: 12-15 mmHg (high enough for adequate preload, low enough to prevent pulmonary edema)
• If using echocardiography: assess IVC diameter and collapsibility, LV end-diastolic volume
• Avoid routine fluid boluses—this patient likely needs diuresis, not volume

The 2008 ACC/AHA guidelines note that in acute severe MR with hypotension, "nitroprusside should not be administered alone, but combination therapy with an inotropic agent (such as dobutamine) and nitroprusside is of benefit" 3. This underscores that afterload reduction and inotropic support—not volume—are the therapeutic priorities.

Specific Fluid Recommendations

If hypovolemic (unlikely given heart failure):

• Small crystalloid boluses: 250-500 mL aliquots maximum
• Reassess hemodynamics after each bolus
• Stop immediately if PCWP rises >18 mmHg or pulmonary edema worsens

More likely scenario—volume overload:

• Initiate diuresis with IV loop diuretics
• Target net negative balance of 500-1000 mL/day initially
• Monitor for worsening renal function but prioritize cardiac output

Maintenance fluids:

• Minimal maintenance: 40-60 mL/hour of crystalloid
• Primarily as carrier for medications
• Consider concentrating drips to minimize volume

Hemodynamic Support Strategy

Given the severe LV dysfunction, inotropic support is essential rather than volume loading:

• Dobutamine 2.5-10 mcg/kg/min to augment contractility and cardiac output 3, 4
• Consider milrinone if inadequate response (particularly beneficial with concurrent pulmonary hypertension) 4
• Vasopressors (norepinephrine or phenylephrine) to maintain MAP >65 mmHg without increasing preload 1, 4

The 2012 TAVR consensus document emphasizes maintaining mean arterial pressure >75 mmHg in patients with severe LV dysfunction to prevent the "cycle of hypotension, subendocardial ischemia, low output and further hypotension" 4.

Splenic Infarction Considerations

The large splenic infarction adds complexity but should NOT drive aggressive fluid resuscitation:

Monitoring for complications:

• Splenic infarction is common in left-sided endocarditis (40% of cases) but only 5% progress to abscess 5
• Watch for: persistent fever, recurrent bacteremia, left upper quadrant pain, or signs of rupture
• Serial imaging (CT/MRI) if clinical deterioration 5

Anticoagulation management:

• Continue heparin as indicated for prosthetic valve (per your GDMT)
• Monitor closely for hemorrhagic transformation of infarct
• Splenic rupture with hemorrhage is rare but catastrophic 5

Surgical considerations:

• If splenic abscess develops: splenectomy is definitive treatment and should be performed BEFORE valve surgery if possible to prevent prosthetic valve seeding 5
• If emergent valve surgery needed: consider simultaneous splenectomy if abscess present 6

Critical Pitfalls to Avoid

1. Do not give empiric fluid boluses assuming "sepsis = fluids needed"—this patient's primary problem is cardiogenic shock, not distributive shock
2. Do not target CVP or static filling pressures alone—use dynamic measures (stroke volume variation, pulse pressure variation) or direct cardiac output monitoring
3. Do not delay inotropes while attempting fluid resuscitation—the EF of 15-20% means this heart cannot respond to preload augmentation
4. Do not overlook worsening MR—acute changes in loading conditions can worsen regurgitation and precipitate acute decompensation 3

Practical Algorithm

1. Establish invasive monitoring (PA catheter or serial echo)
   ↓
2. Assess current volume status:
   - If PCWP >18 mmHg or pulmonary edema → DIURESE
   - If PCWP 12-18 mmHg → MAINTAIN current status
   - If PCWP <12 mmHg AND CI <1.8 → Small fluid challenge (250 mL)
   ↓
3. Initiate inotropic support (dobutamine ± milrinone)
   ↓
4. Add vasopressor if MAP <65 mmHg despite inotropes
   ↓
5. Minimize maintenance fluids (40-60 mL/hr)
   ↓
6. Reassess hemodynamics every 2-4 hours
   ↓
7. Monitor for splenic complications (fever, pain, bleeding)

The 2025 ESICM guidelines confirm that echocardiography-guided fluid management in mechanically ventilated shock patients leads to less fluid administration and improved outcomes 2.